Glutamate regulates caveolin expression in rat hippocampal neurons

Journal of Neuroscience Research

Volumn 72, Issue 2, 2003, Pages 185-190

  Bu, Jing ^a,b   Bruckner, Shane R ^a   Sengoku, Tomoko ^a   Geddes, James W ^a   Estus, Steven ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

Apoptosis; Caveolae; Excitotoxicity

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CAVEOLIN; CAVEOLIN 1; CHOLESTEROL; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; KAINIC ACID; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAVEOLA; CELL MEMBRANE; CELL STRUCTURE; EMBRYO; HIPPOCAMPUS; HOMEOSTASIS; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MACROMOLECULE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLIN 1; CAVEOLINS; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; GENE EXPRESSION REGULATION; GLUTAMIC ACID; HIPPOCAMPUS; NEURONS; NEUROTOXINS; RATS; RECEPTORS, AMPA; RECEPTORS, KAINIC ACID; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0037446104     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10556     Document Type: Article

References (20)

1. Bilderback TR, Gazula VR, Lisanti MP, Dobrowsky RT. 1999. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J Biol Chem 274:257-263.
2. Braun JE, Madison DV. 2000. A novel SNAP25-caveolin complex correlates with the onset of persistent synaptic potentiation. J Neurosci 20: 5997-6006.
3. Brewer GJ, Torricelli JR, Evege EK, Price PJ. 1993. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serumfree medium combination. J Neurosci Res 35:567-576.
4. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 9:9.
5. Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J Biol Chem 272:16374-16381.
6. Estus S. 1997. Optimization and validation of RT-PCR as a tool to analyze apoptotic gene expression. In: Poirier J, editor. Neuromethods 29: apoptosis techniques and protocols. Totowa, NJ: Humana Press. p. 67-84.
7. Estus S, Zaks W, Freeman R, Gruda M, Bravo R, Johnson E. 1994. Altered gene expression in neurons during programmed cell death; identification of c-jun as necessary for neuronal apoptosis. J Cell Biol 127:1717-1727.
8. Estus S, Tucker HM, van Rooyen C, Wright S, Brigham E, Wogulis M, Rydel R. 1997. Aggregated amyloid-β protein induces cortical neuronal apoptosis and concomitant "apoptotic" pattern of gene induction. J Neurosci 17:7736-7745.
9. Fra AM, Williamson E, Simons K, Parton RG. 1995. De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659.
10. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Jr., Kneitz B, Edelmann W, Lisanti MP. 2001. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t- tubule abnormalities. J Biol Chem 276:21425-21433.
11. Galbiati F, Volonte D, Gil O, Zanazzi G, Salzer JL, Sargiacomo M, Scherer PE, Engelman JA, Schlegel A, Parenti M, Okamoto T, Lisanti MP. 1998. Expression of caveolin-1 and -2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA 95:10257-10262.
12. Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, Storm D, Yanagihara T, Hori M, Matsumoto M. 2001. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci 21:9204-9213.
13. Meldrum BS. 2000. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130(4S Suppl):1007S-1015S.
14. Peiro S, Comella JX, Enrich C, Martin-Zanca D, Rocamora N. 2000. PC12 cells have caveolae that contain TrkA. Caveolae-disrupting drugs inhibit nerve growth factor-induced, but not epidermal growth factorinduced, MAPK phosphorylation. J Biol Chem 275:37846-37852.
15. Razani B, Lisanti MP. 2001. Caveolin-deficient mice: insights into caveolar function human disease. J Clin Invest 108:1553-1561.
16. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell KG, Di Vizio D, Hou H, Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138.
17. Rudd PM, Wormald MR, Wing DR, Prusiner SB, Dwek RA. 2001. Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry 40:3759-3766.
18. Schlegel A, Lisanti MP. 2001. The caveolin triad: caveolae biogenesis, cholesterol trafficking, and signal transduction. Cytokine Growth Factor Rev 12:41-51.
19. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, Lisanti MP. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19:7289-7304.
20. Tansey MG, Baloh RH, Milbrandt J, Johnson EM, Jr. 2000. GFRalphamediated localization of RET to lipid rafts is required for effective downstream signaling, differentiation, and neuronal survival. Neuron 25:611-623.